Literature DB >> 22627591

Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort.

Michael Caspers1, Anna Pavlova, Julia Driesen, Ursula Harbrecht, Robert Klamroth, Janos Kadar, Ronald Fischer, Bettina Kemkes-Matthes, Johannes Oldenburg.   

Abstract

Deficiencies of natural anticoagulant proteins including antithrombin (AT), protein C (PC) and protein S (PS) are important causes of inherited thrombophilia. This study aimed to report on the practical experience gained in performing genetic analyses of a large cohort of patients with AT, PC and PS deficiencies and to relate this knowledge to clinical application. We genotyped a large cohort of 709 unrelated patients with AT (231), PC (234) and PS (244) deficiencies referred to us by physicians throughout Germany. Mutations were detected by direct sequencing and multiplex ligation-dependent probe amplification (MLPA). The highest mutation detection rate (MDR) was found for the SERPINC1 gene (83.5%), followed by the PROC (69%) and PROS1 (43%) genes. Even at AT activities close to the normal range (75%), the MDR was 70%. Contrastingly, for PC and PS deficiencies, the MDR dropped significantly and mildly lowered to subnormal values. At PS activities >55% for PS no mutations were detected. Mutation profiles of all three genes were similar with the highest prevalence for missense mutations (63-78%), followed by nonsense (7-11%), splice-site mutations (7-13%), small deletions (1-8%), small insertions/duplications (1-4%) and large deletions (3-6%). In conclusion, genetic testing is a useful diagnostic tool for diagnosing thrombophilia. Based on our data, genetic analysis for patients with AT deficiency is indicated for all subnormal activities. In contrast, genotyping is not advisable for PC activities >70% and for PS activities >55%.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22627591     DOI: 10.1160/TH11-12-0875

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  21 in total

Review 1.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

2.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

3.  Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients.

Authors:  Akiko Sekiya; Fumina Taniguchi; Daisuke Yamaguchi; Sayaka Kamijima; Shonosuke Kaneko; Shiori Katsu; Miho Hanamura; Mao Takata; Haruka Nakano; Hidesaku Asakura; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2016-11-17       Impact factor: 2.490

4.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

5.  Henoch-Schönlein Purpura Nephritis and Cerebral Venous Sinus Thrombosis Due to Hereditary Deficiency of Antithrombin III.

Authors:  Heyan Wu; Pei Zhang; Mei Lu; Ren Wang; Meiqiu Wang; Zhengkun Xia; Chunlin Gao
Journal:  Indian J Pediatr       Date:  2019-10-17       Impact factor: 1.967

6.  Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.

Authors:  Masako Ichiyama; Shouichi Ohga; Masayuki Ochiai; Koichi Tanaka; Yuka Matsunaga; Takeshi Kusuda; Hirosuke Inoue; Masataka Ishimura; Tomohito Takimoto; Yui Koga; Taeko Hotta; Dongchon Kang; Toshiro Hara
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

7.  Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.

Authors:  Hee-Jin Kim; Ja-Young Seo; Ki-O Lee; Sung-Hwan Bang; Seung-Tae Lee; Chang-Seok Ki; Jong-Won Kim; Chul Won Jung; Duk-Kyung Kim; Sun-Hee Kim
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

8.  A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms.

Authors:  Io Kato; Yuki Takagi; Yumi Ando; Yuki Nakamura; Moe Murata; Akira Takagi; Takashi Murate; Tadashi Matsushita; Tadaaki Nakashima; Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2014-06-03       Impact factor: 2.490

9.  Genetic Analysis of a Pedigree With Antithrombin and Prothrombin Compound Mutations and Antithrombin Heterozygotes.

Authors:  Haiyue Zhang; Yiling Hu; Dongli Pan; Yuehua Xv; Weifeng Shen
Journal:  Front Genet       Date:  2022-04-04       Impact factor: 4.772

10.  Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.

Authors:  Teena Bhakuni; Amit Sharma; Qudsia Rashid; Charu Kapil; Renu Saxena; Manoranjan Mahapatra; Mohamad Aman Jairajpuri
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.